Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Eppendorf Launches the New Electronic Pipette Controller Easypet® 3

Published: Thursday, May 23, 2013
Last Updated: Wednesday, May 22, 2013
Bookmark and Share
Lightweight, well-balanced and extremely easy to use.

Eppendorf has launched the new aid for electronic pipetting, Easypet 3. Replacing the existing model, the new model gives greater accuracy by controlling the speed conveniently and intuitively with the use of the operating buttons.

The new Easypet 3 boasts decreased battery charging time to 3 hours, allowing for increased cordless operation time. With its lightweight ergonomic design Easypet 3 enables stress-free pipetting.

Easypet 3 promotes reliability, ease of use and simplicity. Operation buttons are ergonomically shaped, making aspirating and dispensing of liquids easier.

Increased or reduced pressure on the buttons regulates speed for precise measurements. Vibrant backlit LEDs highlight the battery status contributing to the user’s peace of mind.

Easypet 3 delivers efficient performance through a high-powered motor speeding up the pipetting process and can be used with any type of pipettes from volumes of 0.1 - 100 mL.

Easypet 3 is also able to be operated while recharging, ensuring that the workflow is not interrupted. Easypet 3 has been designed with the user in mind.

It is lightweight, well-balanced and extremely easy to use. Being cordless, it enables flexibility in the laboratory allowing the user to freely move around the workplace.

The ergonomic design includes a hand rest and wall mount that support long-term use.

The Easypet 3 was awarded with the red dot design award 2013 that recognizes high quality.

Eppendorf has already won several design awards for its innovative, top-quality lab products in the past.

The red dot product design award 2013 continues this tradition.


Further Information

Join For Free

Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 3,300+ scientific posters on ePosters
  • More than 4,900+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
Gene-Editing 'Toolbox' Targets Multiple Genes Simultaneously
Researchers have designed a system that modifies, or edits, multiple genes in a genome at once while minimising unintentional effects.
Discovering the First Farmers
Genetic analyses reveal a collection of highly distinct groups in the Near East and Europe at the dawn of agriculture.
Mutations in DNA-Repair Genes Found in Advanced Prostate Cancers
New findings indicate that nearly 12% of male advanced prostate cancer sufferers have inherited mutation in DNA-repair genes.
Ice Bucket Challenge Instrumental in Gene Discovery
Donations from the ALS Ice Bucket Chellenge allowed for the largest-ever study of inherited ALS, which identified a new ALS gene.
Triple-Action Therapy Patch Shows Promise
Patch that delivers drug, gene, and light-based therapy to tumor sites shows promising results in mice.
Cancer Gene-Drug Combinations Ripe for Precision Medicine
The study aims to expand the number of cancer gene mutations that can be paired with a precision therapy.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Colon Cancer Blocked in Mice
Case Western Reserve University Researchers block common type of colon cancer tumour in mice, laying groundwork for human clinical trial.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!